ABSTRACT Antimicrobial peptides (AMPs) are expressed in various living organisms as first-line host defenses against potential harmful encounters in their surroundings. AMPs are short polycationic peptides exhibiting various antimicrobial activities. The principal antibacterial activity is attributed to the membrane-lytic mechanism which directly interferes with the integrity of the bacterial cell membrane and cell wall. In addition, a number of AMPs form a transmembrane channel in the membrane by self-aggregation or polymerization, leading to cytoplasm leakage and cell death. However, an increasing body of evidence has demonstrated that AMPs are able to exert intracellular inhibitory activities as the primary or supportive mechanisms to achieve efficient killing. In this review, we focus on the major intracellular targeting activities reported in AMPs, which include nucleic acids and protein biosynthesis and protein-folding, protease, cell division, cell wall biosynthesis, and lipopolysaccharide inhibition. These multifunctional AMPs could serve as the potential lead peptides for the future development of novel antibacterial agents with improved therapeutic profiles.
L
iving in a complex environment, various life forms from single-cell to multicellular higher organisms are constantly interacting with each other. Such interactions include challenges that are harmful to the host. One of the important defensive strategies is the expression of antimicrobial peptides (AMPs). AMPs are short peptides (8 to 50 amino acids) of low molecular weight, the majority of which are cationic, contain multiple hydrophobic residues, are amphiphatic, and exhibit broad-spectrum antimicrobial activity (1) (2) (3) (4) (5) . Different classes of AMPs have been discovered in various organisms from mammals, arachnids, amphibians, plants, fungi, and even single-cell microorganisms (6, 7) . In humans, AMPs can be supplemented by immune cells (e.g., mast cells, macrophage, and neutrophils) at injury sites during the acute inflammatory response (8) (9) (10) . Also, secretory AMPs are constitutively expressed and released into the oral cavity, gastrointestinal tract, and respiratory tract as part of mucosal innate immunity (11, 12) . In the event of acute infection or the presence of infection stimuli, the expression of AMPs can be dramatically induced (13) .
AMPs are commonly known for their non-receptor-mediated membrane-lytic bactericidal activity (14, 15) . Three membrane disruption models by AMPs had been proposed (1): toroidal-pore, barrel-stave, and carpet models (Fig. 1 ). In the toroidal-pore model, initial binding of peptide to the membrane is followed by cascade aggregation of incoming monomer units, causing the lipid moieties of outer and inner membranes to fold inward, forming a continuous channel lined by multiple peptide units (16) . The lipid head groups of membrane phospholipids are thus tightly associated with the peptides. Examples include melittin (17) , magainin 2 (18) , and lacticin Q (19) . The barrel-stave model differs from the toroidal-pore model in that the peptide monomers inserted into the membrane are arranged parallel to the phospholipid molecules of the membrane. The lumen of the transmembrane channel will thus be lined by the hydrophilic side of the peptides, while the hydrophobic side will be facing outward in association with the lipid core of the bilayers (16) . An example of an AMP of this type is alamethicin (20) . For the carpet model, the cumulative effect of peptides interacting with the outer membrane would induce local weaknesses disintegrating the membrane structure, giving a carpet-like appearance (16) . An example of a carpet model AMP is cecropin P1 (21) .
In recent years, there have been increasing documentations of intracellular targeting AMPs (1, 16, 22) . These AMPs are able to traverse the cell barriers to reach the target components in the cytoplasm of the cells. The uptake process of AMPs generally occurs via direct penetration or endocytosis (23) . Endocytosis follows either micropinocytosis or receptor-mediated pathways (24) . In micropinocytosis, dynamin facilitates the formation of AMP-carrying macropinosomes derived from the cell membrane (23) . In a receptor-mediated pathway, formation of small vesicles in the cytoplasm is preceded by pit formation mediated by clathrin or caveolin membrane proteins (24, 25) .
A number of AMPs are known to serve two or more inhibitory functions. A peptide that exerts a bactericidal effect via membrane disruption might in turn kill other bacteria using nonmembrane-lytic pathways, and vice versa (16) . The activities of AMPs are dependent upon various factors, including temporal separation (simultaneous or sequential), concentration of AMPs, bacterial growth phase, species, and Gram stain, in a cooperative manner to ensure efficient and rapid killing (22, 26, 27) . Conversely, AMPs with widely dissimilar primary sequence and solution structure may inhibit common pathways, as seen with histatin 5 and human neutrophil defensin-1 (HNP-1) (28) . Such indispensable roles in the host throughout evolution clearly imply that the membrane and nonmembrane mechanisms of AMPs serve equally important functions.
Unfortunately, the general environment in the field in past decades has focused much on the discovery of natural AMPs and design of AMP analogues. Investigating the alternative mechanisms of AMPs has gained interest only in the past 10 years. With the enormous pool of AMP leads available in the literature, the previously overlooked aspects of AMPs should be discovered and rediscovered. From a technical perspective, the commonly performed methods (electron microscopic imaging, dye leakage, and gel retardation assays) do describe the killing mechanisms of AMPs but are otherwise insufficient to pinpoint the actual interacting components or binding sites. Microscopy imaging using fluorescent probe/radiolabel localization in the treated cells, pulldown assay, proteomic array, whole-genome sequencing, and other newer platforms would be valuable to determine the interactions.
In this review, AMPs exhibiting nonmembrane-lytic antibacterial activities are discussed to provide a greater understanding of the mechanisms of actions of multifunctional AMPs as the potential next-generation antibiotics.
NUCLEIC ACID BIOSYNTHESIS AND METABOLISM INHIBITORS
Buforins are a class of DNA inhibitor first isolated from the stomach tissues of the Asian toad (Bufo bufo gargarizans) (29) . Buforin II, a 21-amino-acid fragment peptide derived from endoproteinase Lys-C enzymatic cleavage of buforin I, was able to induce membrane permeation in Escherichia coli (30) . The presence of a proline hinge region in buforin II is critical for its transmembrane activity (30, 31) . Interestingly, membrane leakage was not observed even at a concentration 5-fold above the MIC (31, 32) . Results from a gel-retardation experiment showed that buforin II exhibited high nucleic acid binding affinity. This strongly implies that buforin II inhibits cellular processes by interrupting DNA and RNA metabolisms (32) . Later, it was determined that the parent peptide buforin I possessed high sequence homology (94.49%) to the N-terminal fragment of the DNA-binding protein histone H2A, leading to speculation that AMPs with structures resembling histone H2A (e.g., parasin I and hipposin, derived from skin mucus of catfish [33] ) would exert antimicrobial activity in a fashion similar to that of buforin II (30, 32) . Two designed analogues of buforin II were shown to inhibit nucleic acid metabolisms with 4-fold greater DNA-binding affinity in BF2-C than BF2-A (34). In contrast, BF2-A bound more tightly to the single-strand RNA. Based on sequence analysis, it appeared that the C-terminal regular ␣-helical motif RLLR contributed toward the stronger double-helix DNA-binding affinity in BF2-C. We have summarized a list of AMPs with reported intracellular targeting activities discussed in this review in Table 1 . An illustration indicating the intracellular targets sites of AMPs is shown in Fig. 2 .
The 13-amino-acid indolicidin is a C-terminally amidated polycationic tryptophanrich AMP derived from the cytoplasmic granules of bovine neutrophils. Indolicidin belongs to the cathelicidin family of AMPs (35) . Membrane permeation induced by indolicidin at high concentration does not lead to cell lysis (36) (37) (38) (39) ; rather, the increased permeabilization facilitates continuous peptide entry into the cytosol to inhibit DNA biosynthesis exclusively, but not RNA (40) . The peptide specifically targets the abasic site of DNA to cross-link with single-or double-stranded DNA (41) (43) .
Besides direct DNA binding, indolicidin prevents DNA relaxation by inactivation of DNA topoisomerase I (41). Interestingly, this step occurs without unwinding of the DNA helix, further suggesting the multiple inhibitory roles of indolicidin against various DNAassociated enzymes. The presence of homologous sequence in other DNA-binding proteins (e.g., DNA methyltransferase) indicates that the N-terminal fragment of indolicidin, rather than the PWWP motif, is responsible for its DNA-binding activity (41) . Indolicidin has also been demonstrated to bind calmodulin at high affinity in a Ca 2ϩ -dependent fashion (44) .
The ostrich-derived ␤-defensins ostricacin-1 (Osp-1) and ostricacin-2 (Osp-2) exhibited antibacterial activity against Gram-negative bacteria by binding to and inhibiting DNA (45) . These AMPs have been shown to interfere with protein biosynthesis and enzymatic activities in the target bacterial cells. On the other hand, Oabac5mini is an AMP isolated from ovine neutrophils displaying strong DNA-binding affinity in bacterial cells (45, 46) . Tachyplesin, isolated from hemocytes of horseshoe crab (Tachypleus c tridentatus), is also a DNA-binding peptide (47) . It contains a unique antiparallel beta-sheet secondary structure to bind to the minor groove of DNA duplex (48) .
Microcins are a group of enterobacterial AMPs classified into one of seven major groups (A, B, C, D, E, H, and J) based on cross-immunity criteria (49) (50) (51) . The 43-residue microcin B17 is the first AMP found to inhibit type II DNA topoisomerase (gyrase), reminiscent of the conventional quinolone antibiotics (52) (53) (54) . Microcin B17 is produced by E. coli harboring the plasmid-borne MccB17 operon (55, 56) . It blocks DNA replication by trapping the gyrase-DNA complex, halting subsequent processes (52, 57) . B17 specifically targets the C-terminal domain of gyrB of the gyrase tetramer, which consists of gyrA and gyrB subunits. This inhibits the ATP hydrolysis activity responsible for the proper negative supercoiling of DNA. OmpF is important for the translocation of microcin B17 across the outer membrane and SbmA across the inner membrane into the bacterial cells (58) .
Another type of microcin 25 (mcc25 or J25) isolated from the E. coli fecal strain AY25 is a potent antibacterial peptide, particularly against Gram-negative bacteria, including the closely related Shigella and Salmonella genera (59, 60) . Entry of J25 into the cell is facilitated by the outer membrane receptor FhuA (61) . After passing the first barrier, ExbD, ExbB, and SbmA are responsible for peptide transport across the inner membrane into the cytoplasm (62) . Microcin J25 disrupts transcription by binding to beta=, which represents the largest bacterial RNA polymerase subunit encoded by rpoC (63) . Binding of J25 blocks substrate access to the catalytic center of RNA polymerase (64) . This stops transcript elongation temporarily but does not alter the elongation velocity between pauses (65). Adelman and colleagues showed that J25 can be cross-linked to the 3= end of the nascent RNA of the elongation complexes to inhibit the GreA/GreBdependent transcript cleavage pathway and cease backtracked complex formations (65) . It was found that in J25-resistant E. coli strains, a mutation in rpoC leads to the alteration of amino acids in the conserved G, G=, and F segments within the secondary channel (63) .
PROTEIN BIOSYNTHESIS AND METABOLISM INHIBITORS
The concerted events of protein synthesis begin from DNA transcription to mRNA, followed by translation of mRNA via the 70S bacterial ribosomal machinery to polypeptides before undergoing chaperone-assisted folding and assembly into functional proteins. Interference with any of the associated enzymes or effector molecules could result in protein biosynthesis arrest. There are AMPs shown to inhibit these targets to achieve bacterial cell killing.
Bac7 is a considerably large 60-residue AMP isolated from the large granules of bovine neutrophils. The N-terminal 35-residue fragment (Bac7 1-35) appears to be responsible for biological activity of the intact Bac7 (66) . Interestingly, Bac7 1-35 exerts intracellular activity when present at near-MIC level, following stereospecific-dependent uptake that would become membranolytic at a concentration 64-fold greater than the MIC, independent of stereospecificity (67) . Internalization of Bac7 1-35 is mediated by the inner membrane protein SbmA. E. coli mutants with an sbmA-null or sbmA point mutation have been shown to develop resistance against Bac7 1-35 (68). Bac7 1-35 inhibits protein translation by targeting the ribosomes (69) . Proteome analysis found that Bac7-treated E. coli bacteria showed functional enrichment in a number of pathways involving nucleic acid metabolism, including nucleotide transport and metabolism, nucleobase, nucleoside, and nucleotide interconversion (70) . A previous study reported that Bac7 1-35 conferred protection against endotoxin-induced septic shock in an experimental rat model (71) .
Protein synthesis arrest was also observed in E. coli treated with sublethal dose of pleurocidin (72) . When given at the lethal dose, pleurocidin became both bactericidal and inhibited protein, DNA, and RNA synthesis (73) . This was evident through observations of a reduction in the incorporation of histidine, uridine, and thymidine in pleurocidin-treated cells (73) .
The 13-residue CP10A is a synthetic variant of indolicidin (74) belonging to the cathelicidin family of polypeptides (75) . Previous studies documented that indolicidin and its synthetic analogues exhibited strong inhibitory effects against bacteria, fungi, and viruses (35, (76) (77) (78) . In addition to membrane lysis, CP10A exerted diverse intracellular inhibitory activities against DNA, RNA, and protein synthesis (74) . By using Staphylococcus aureus as the model organism, cells treated with CP10A had reduced incorporation of histidine, uridine, and thymidine (74) .
In our previous study, the hybrid peptide DM3 exhibited broad-spectrum antibacterial activity with rapid bactericidal potency (79) . In particular, standalone DM3 treatment significantly enhanced the survival rate of mice lethally infected with pneumococcal systemic infection compared to the untreated control group (80). Whole-genome transcriptomic analysis found that a number of important intracellular pathways were significantly affected. These include the expression of genes associated with DNA replication and transcription, ribosomal rRNA subunits, amino acid biosynthesis pathway, and downregulation of RpoD and RNA polymerase sigma factor (81) . Downregulation of the cationic AMP resistance pathway indicated that DM3 treatment could autoenhance pneumococcal susceptibility to DM3 and other AMPs, thus reducing the chance of AMP resistance developing in the treated cells.
PR-39 is a 39-residue proline-rich (49%) and arginine-rich (24%) AMP first isolated from porcine small intestine (82) and subsequently from porcine and human neutrophils (83) . Internalization of PR-39 is also mediated by the membrane receptor SbmA (68, 84) . The primary mechanism of action of PR-39 is attributable to its rapid proteolytic activity causing the degradation of some DNA replication-associated proteins, leading to secondary inhibition of DNA synthesis events (85) . Recent data obtained using a proteome microarray have confirmed the inhibitory effects of PR-39 in a number of metabolic pathways, including those for translation, nucleotide transport and metabolism, coenzyme transport and metabolism, and others (70) .
Apidaecin-type peptides are a group of 18-to 20-amino-acid proline-and argininerich AMPs isolated from honeybees, hornets, and wasps (86) . Apidaecin Hb1a displays selective antibacterial activity, mainly against Gram-negative bacteria (87) (88) (89) . Significant loss of antimicrobial activity with the all-D-enantiomer analogues showed that the biological functionality of apidaecin required high stereospecificity (90) . Even though most AMPs do exhibit certain levels of membrane-lytic activity, apidaecin Hb1a is a rare exception, possessing no pore-forming or membrane disruption activity (90) . Entry of apidaecin Hb1a into E. coli begins with the initial nonspecific contact with the outer membrane component to enter the periplasmic space, followed by irreversible binding of peptide to the inner membrane or otherwise-bound receptors. The ABC transporter system was suggested to be the potential candidate responsible for apidaecin Hb1a uptake into the cells (88) . Subsequently, the peptide will be translocated intracellularly to inhibit the protein synthesis pathway by targeting the ribosomes (88) .
Lactoferricin B was the first AMP shown to interfere with phosphorylation of the two-component system to suppress bacterial growth (91) . It inhibits phosphorylation of the two response regulators by their cognate sensor kinases BasS and CreC. Pyruvate accumulation has also been reported in bacterial cells treated with lactoferricin B (92) .
HNP-1 belongs to one of four ␣-defensin variants (HNP-1 to HNP-4) in human neutrophil azurophilic granules (93) . Interestingly, HNP-1 induced sequential permeabilization of both the outer and inner membranes of E. coli, accompanied by DNA, RNA, and protein synthesis failures (94) . For HNP-1, loss of inner membrane integrity appeared to be the key event associated with lethality. Besides that, lactoferricin B, PR-39, P-Der, and Bac7 were found to inhibit the arginine decarboxylase pathway and 30 other common proteins in E. coli-treated cells (70) . Interference with arginine decarboxylase activity could reduce survival fitness of the host cells, especially under highly acidic conditions, thus reducing the pathogenicity of the bacteria. Other AMPs, such as defensins and dermaseptin, also possessed protein synthesis inhibitory activity (95) .
PROTEIN-FOLDING INHIBITORS
Chaperones are proteins crucial for the proper folding and assembly of newly synthesized proteins (96) . DnaK is the major bacterial heat shock protein 70 (Hsp70) and represents an important component in E. coli chaperone pathways (97) . A group of short (18-to 20-amino acid) proline-rich insect-derived AMPs are able to inhibit bacterial growth by interrupting the protein-folding pathway. This includes pyrrhocoricin, isolated from the hemipteran insect fire bug Pyrrhocoris apterus (98) , apidaecin, and Drosophila drosocin, originally discovered in the bean bug (Riptortus clavatus) (99) . In its solution form, pyrrhocoricin, apidaecin, and drosocin interact strongly with bacterial lipopolysaccharides (LPS), suggesting that the multiple inhibitory events essentially begin with the initial contact against a bacterial cell wall component (100) . Both pyrrhocoricin and apidaecin inhibit DnaK and GroEL as well as disrupt the ATPase activity of DnaK (101, 102) . In contrast, drosocin inactivates DnaK and GroEF (100). Both pyrrhocoricin and drosocin prevent DnaK from refolding misfolded proteins by inducing permanent closure of the DnaK peptide-binding cavity (102) . Binding of these three AMPs to DnaK is essentially stereospecific, which is advantageous in term of cell selectivity to prevent toxicity, as they do not target the human equivalent chaperone Hsp70 (100).
DnaK-binding activity has similarly been described for abaecin, an AMP isolated from the bumblebee Bombus pascuorum. Experimental results recorded a 74% quenching effect by abaecin, with a disassociation efficiency comparable to that of other proline-rich DnaK-targeting peptides, such as oncocin and pyrrhocoricin (103) . Unlike the proline-rich AMPs (onc72, api88, drosocin, and pyrrhocoricin), which possess the DnaK-binding YL/IPRP motif, the WPYPLPN fragment was predicted to be the primary binding region in abaecin. Oncocin, a 19-amino-acid proline-rich AMP derived from Oncopeltus antibacterial peptide 4, exhibits potent antibacterial activity against Gramnegative bacteria (104) . The peptide penetrates the bacterial membrane freely, without causing lytic effect to the cells (104) . Following that, it was demonstrated that oncocin formed a complex with DnaK, indicating the protein-folding inhibitory activity of this peptide (105) . Apart from targeting the protein biosynthesis mechanisms, Bac7 1-35 also displayed high binding affinity to DnaK and inhibited the protein-refolding function of the DnaK-DnaJ-GrpE-ATP molecular chaperone system in a concentrationdependent manner (106) .
PROTEASE INHIBITORS
Host matrix metalloproteases (MMPs) serve to function as the principal enzymes in the normal turnover of extracellular matrix. Dysregulation of MMPs and bacterial proteases are associated with oral diseases, arthritis, periodontitis, and tumor metastasis (107) .
Histatin 5 is a member of the histatins, a group of histidine-rich cationic peptides present in the salivary secretions of human submandibular and parotid glands (108, 109) . Histatin 5 is a potent antifungal peptide acting upon multiple intracellular components to induce oxidative stress and mitochondrial malfunction in Candida albicans (110) . However, its direct antibacterial activity has only been described for Streptococcus mutans (111), one of the major oral bacteria implicated in dental caries (112) . What is interesting about histatin 5 is its strong inhibitory activity against the host-and bacterium-secreted proteases. In a study by Gusman et al., the 50% inhibitory concentration (IC 50 ) levels of histatin 5 against human MMP-2 and MMP-9 were recorded at 0.57 and 0.25 M, respectively (113) . In a separate study, they observed higher binding affinity of histatin 5 than for leupeptin (114) , a competitive inhibitor of the cysteine proteinase clostripain produced by the anaerobic bacterium Clostridium histolyticum that causes gas gangrene (115) . Overproduction of cysteine proteinases and collagenases could lead to extensive necrotizing muscle tissue breakdown. Besides, histatin 5 specifically inhibits a trypsin-like protease but not other proteases produced by the oral bacterial pathogen Porphyromonas gingivalis (116) . The peptide also displays competitive inhibition against Arg-gingipain, while both competitive and noncompetitive mechanisms are involved upon complex formation with Lys-gingipain (113) . Based on the findings, histatin 5 could serve as a potential therapeutic agent to reduce extracellular matrix degradation caused by host-and bacterium-secreted proteases in periodontal diseases.
Equine leukocytes contain eNAP-2, an AMP exhibiting antibacterial activity against E. coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Streptococcus zooepidemicus (117) . This peptide selectively forms a noncovalent complex with the microbial serine proteases subtilisin A and proteinase K but not the mammalian serine proteases (118) . Selective inactivation of microbial serine proteases by eNAP-2 represents an important host defense mechanism against microbial infection in horses. Ixodidin is a considerably large 65-residue cysteine-rich AMP isolated from tick (Boophilus microplus) hemocytes. This AMP inhibits proteases, such as elastase and chymotrypsin, to induce cellular metabolism cessation (119).
CELL DIVISION INHIBITORS
There are AMPs demonstrated to have significant inhibitory activity on bacterial cell processes. Cell filamentation might occur as a result of inhibition of DNA replication, SOS induction, chromosome segregation, or failure of septation process (120) . As shown by Salomón and Farías, E. coli treated with microcin J25 became significantly elongated, resulting in a filamentous morphology, but septation was otherwise not initiated, thus prohibiting the cell division processes (59) . It was found that microcin J25 acted on a non-SOS-dependent mechanism, and this confirmed its bacteriostatic mode of action (59) . Similar to microcin J25, E. coli treated with diptericin had a significantly elongated morphology, suggesting that diptericin may act upon cellular targets in-volved in cell division to induce cell death (121) . Notably, diptericin was effective against actively growing E. coli but not cells at its resting state (121) .
The human ␣-defensin 5 (HD5) is able to traverse the outer membrane and impairs the inner membrane of E. coli (122, 123) . Peptide entering the cytosol will then induce multiple cellular damages, as observed with blebbing and clumping of cells. Extensive elongation of cells was also noted, indicating disruption to cell division events (124) . Such treatment outcomes were observed in P. aeruginosa, K. pneumoniae, and Acinetobacter baumannii, suggesting that HD5 produced a common inhibitory activity against Gram-negative bacteria. AMP-induced filamentation had also been described with indolicidin (40), PR39, and the truncated variant PR26 (83) .
CELL WALL BIOSYNTHESIS INHIBITORS
Cell wall compositional differences and the presence of capsular polysaccharide in certain bacteria (e.g., Streptococcus pneumoniae) are important factors influencing the potency and antibacterial selectivity of AMPs. The bacterial cell wall consists of alternating amino sugars in linear form that cross-link via peptide bridges to form the peptidoglycan layer (125) . Lipid II is an important component in peptidoglycan synthesis. It resides at the cytoplasmic face of the cell membrane to transport cell wall subunits across the membrane to be polymerized and inserted into the existing cell wall (126) . The bacterial peptidoglycan layer is crucial for the integrity and survival of bacteria and represents the prominent target for a number of antibiotics (127) .
Mersacidin is a globular lantibiotic formed by the presence of four intramolecular thioether bridges (128) . The peptide targets the peptidoglycan precursor lipid II to form a complex with the sugar phosphate head group (129) . Binding of mersacidin to lipid II blocks the transglycosylation step in cell wall biosynthesis (130) . Accumulation of the peptidoglycan precursor complex UDP-MurNAc-pentapeptide has been observed in the cytoplasm of mersacidin-treated bacterial cells (130) . Since mersacidin targets the peptidoglycan biosynthesis pathway, Gram-positive bacteria, such as methicillinresistant S. aureus (MRSA), appear to be more susceptible to the peptide than Gramnegative bacteria and fungi (131, 132 ). An in vivo experiment using a murine rhinitis model reported that mersacidin was able to eradicate MRSA colonization without stimulating inflammatory responses (133) . Moreover, newer evidence showed that human ␤-defensin 3 (HBD3) and HNP-1 were able to bind to lipid II to inhibit cell wall biosynthesis (134, 135) .
Nisin represents the most characterized lantibiotic that acts by membrane pore formation to induce cell lysis (136) . The pore complex is formed between the lanthionine ring A and B complex of nisin with the pyrophosphate group of lipid II (137). Hasper et al. showed that lantibiotics with an N-terminal pyrophosphate group cage displayed an alternative bactericidal mechanism which was lipid II dependent by sequestering lipid II from its intracellular functional site to inhibit cell wall biosynthesis (138) . The finding supported the hypothesis that other lantibiotics possessing similar lanthionine A/B ring structures may exhibit similar mechanisms of action (139) (140) (141) . This might help explain the potent non-pore-forming antibacterial activity of staphylococcin T, gallidermin, and epidermin (142, 143) .
Copsin is extremely resistant to proteolysis and wide range of pH and temperature due to the presence of the unusually high number of (six) disulfide bonds, compared to only three or four in other cysteine-stabilized alpha/beta (CS␣␤) defensins (144) . It is able to bind to the precursor lipid II, particularly at the third position of the pentapeptide, leading to inhibition of cell wall biosynthesis (144) . In addition, the fungal AMP plectasin produced by the saprophytic ascomycete Pseudoplectania nigrella effectively inhibits lipid II for its intracellular activity (145) . Plectasin also displayed high therapeutic efficacy in mouse pneumococcal peritonitis and pneumonia models, with minimal toxicity (146) .
Staphylococcus epidermitis produces the lantibiotic Pep5, which is characterized by the presence of three intramolecular rings (147) . The peptide is involved indirectly in cell wall lysis through the activation of cell wall-associated lytic enzymes (148) . Pep5 exhibits high binding affinity to teichoic and teichuronic acids of the Gram-positive bacterial cell wall, which competitively displaces the cell wall-associated amidases (148) . This leads to premature release of the autolytic enzymes, resulting in cell lysis. Apart from that, transcriptomic analysis revealed that our designed peptide, DM3, downregulated the capsular polysaccharide subunits of penicillin-resistant pneumococci (81) . This implies that DM3 could compromise cell wall biosynthesis activity to weaken and exert bactericidal activity.
In mammalian blood cell granules, defensins expressed in the neutrophil azurophilic granules and the small endogenous cationic peptide platelet microbicidal proteins (PMPs) present within the platelet ␣-granules are two well-characterized AMPs exhibiting very similar antimicrobial activities against C. albicans and S. aureus, E. coli, and other bacteria (94, (149) (150) (151) (152) . Their potent membrane-lytic activities, particularly against S. aureus, have been described in the literature (153) (154) (155) . Previous studies reported that pretreatment of bacteria with the cell wall-targeting antibiotics penicillin and vancomycin would facilitate uptake of the thrombin-activated PMP-1 (tPMP-1) and HNP-1 into the cytoplasm (156) . The observed microbicidal activity by tPMP-1 and HNP-1 might be assisted by the direct activation of autolytic enzyme in the bacterial cells or indirectly via penicillin-and vancomycin-enhanced cell killing. However, these mechanisms are likely the supportive but not primary antibacterial mode of action (156) . Of note, HNPs have also been shown to enhance the susceptibility of bacteria against rifampin, and this indicates that AMPs causing outer membrane permeabilization might act synergistically with conventional antibiotics to improve therapeutic outcome (157) .
LIPOPOLYSACCHARIDE-BINDING PEPTIDES
The LPS layer constitutes the outer leaflet component of the outer membrane of Gram-negative bacteria. The hydrophobic anchor lipid A (LA) molecule (commonly referred to as LPS) of LPS monomer is generally known as the bacterial endotoxin largely responsible for the toxicity and clinical manifestations associated with Gramnegative bacterial infections (158, 159) . LPS can be shed from the cell during the process of infection or the course of antimicrobial chemotherapy treatment (160) . However, in the case of endotoxemia, where endotoxin is being released into the blood, overproduction of inflammatory stimulatory molecules by the immune cells could lead to septic shock (161) (162) (163) . Endotoxin-targeting AMPs have great potential to be developed as antiendotoxin or endotoxin-neutralizing agents in patients with endotoxic shock during or after treatment.
Both MBI-27 (26 amino acids) and MBI-28 (28 amino acids) exhibit antibacterial activities against Gram-negative bacteria (164, 165) . Strikingly, these two peptides were found to bind the purified whole-cell LPS prepared from P. aeruginosa with a binding affinity comparable to that of polymyxin B (164) (165) (166) . MBI-28 was more potent than MBI-27, due to the presence of two additional lysine residues at its C-terminal (164) . AMP binding and neutralization of endotoxin would prevent the uncontrollable activation of inflammatory responses as a result of imbalanced cytokine (e.g., interleukin-1 [IL-1] and tumor necrosis factor alpha [TNF-␣]) production, mainly by the LPSstimulated mononuclear and macrophage cells (167) (168) (169) . Amphipathicity and a high proportion of cationic residues in the AMP sequence have been suggested to be the principal binding motifs against the oppositely charged LA (170) . Even for the relatively short ␤-sheet AMPs, a complex can still be formed between the ␤-sheet cationic side chains and the anionic phosphates of LA (171) . Based on the structural characteristics of the LPS-binding protein family, Muhle and Tam generated two ␤-stranded cyclic AMPs with Ͼ200-fold greater selectivity against the Gram-negative E. coli than the Gram-positive S. aureus (172) .
Magainins represent one of the most studied families of AMPs, well known for their potent membrane-lytic activity. However, the intracellular targeting effects of magainins have not received considerable attention until recently. Comparative proteomic analysis between magainin 1-resistant and -susceptible strains revealed that many proteins associated with energy metabolism (49%) were extensively altered, followed by nitrogen metabolism (12%), amino acid metabolism (7%), stress response (7%), and others (25%) (173) . This study provides strong evidence of the intracellular activities of magainin 1. Microorganisms are able to develop resistance by altering the important cellular components in response to antimicrobial selective pressure to ensure survival.
IMPORTANT REMARKS
AMPs are generally perceived as membrane-active molecules act by perturbation of the cell wall/membrane or via formation of transmembrane pores leading to cell death. Based on the findings collected in this paper and elsewhere, we should now understand that a substantial number of AMPs possess multifunctional activities at membranal and/or intracellular sites to achieve efficient killing. Furthermore, the intracellular inhibitory mechanisms of AMPs serve equally important roles, contributing to the overall antibacterial efficiency. Unfortunately, these aspects are commonly overlooked or unreported.
The factors that determine the modes of action of AMPs are the long-sought answers for researchers in the field and are still largely unclear. As reviewed in this paper, a single AMP could target multiple sites of the bacterial cells, and vice versa. These AMPs varied largely in their sequence identities, and secondary structure alone is not sufficient to explain the findings. Although higher net charge, hydrophobicity, helical propensity, and presence of a conserved sequence are able to enhance the antimicrobial activity of AMPs in general, however, these sets of rules do not apply equally to all classes of AMPs. For example, our previous studies showed that the antibacterial activity of five designed AMPs (DM1 to DM5) was correlated to net charge within specific window values (79, 174, 175) . Anionic AMPs have also been documented in the literature (176, 177) . Other factors, including concentration of peptide, target species, and growth phase of bacteria, have significant influences on the mode of actions of AMPs. For most AMPs, there are conserved fragments which are responsible for biological activity of the peptides. However, designing peptide analogues with improved activity based on these conserved fragments requires more in-depth considerations than cut-and-join strategies. Most importantly, determinants contributing to the antimicrobial activity of a particular class of AMPs are unlikely to be applicable to another unrelated class of AMPs. The determinants of AMPs' mechanisms of actions should involve the complex interplay between the sequence and physicochemical factors and not be treated as discrete dependents.
Given the cascade of events and time required to produce eventual metabolic inhibition in the bacterial cells in contrast to the nonspecific and rapid membrane-lytic activity, an important question may arise whether the bacteria would have better chance of developing resistance against the intracellular acting AMPs than the membrane-active AMPs? This is true, but only partially true. In fact, AMPs are unique in that these molecules exhibit multiple inhibitory actions which could act both nonselectively on cell barriers (cell wall and cell membrane) and selectively against one or more intracellular targets. Interestingly, these mechanisms do not occur independently. The same AMP could simultaneously lyse the membrane and act on intracellular targets of the same cell to exert a killing effect. Under such selective pressures, the likelihood of developing multiple resistances via simultaneous genetic mutations and altered cellular processes would be very low, as such drastic alterations would be too metabolically costly to the survival and pathogenicity of bacteria. Moreover, we postulate that there are AMPs that act via an indirect mechanism by extensive activation of resistance mechanisms, which in turn severely disrupt the normal cellular metabolisms of bacterial cells, leading to a detrimental outcome. The combination of multiple targeting and rapid bactericidal activities would essentially minimize the chance of AMP resistance development in the bacteria.
There has been increasing interest in developing AMPs as cell-penetrating peptides (CPPs) against intracellular infections. For example, LL-37 exhibited extracellular and intracellular bactericidal activities against S. aureus (178). Although it is still unclear if there is a correlation between antimicrobial activity and cell-penetrating capacity, we consider AMPs with strong antimicrobial potential to be the prerequisite to act as an effective CPP, as it is meaningless to have AMP candidates penetrating the host cell at high efficiency but that are otherwise unable to kill the bacteria residing in the host cell. This is an emerging area in AMP research, and many unknowns are yet to be explored. The AMP uptake mechanisms and compositions of bacterial cell wall and cell membrane would be largely different from those in the eukaryotic cell. Additionally, the AMPs must not be cytotoxic to the host cell to be developed as antimicrobial agents.
CONCLUSION
In the face of increasing reports of multidrug-resistant and panresistant bacteria, a novel class of antimicrobials is in extreme demand. Recently, a female patient in her 70s from Nevada, USA, diagnosed with systemic inflammatory response syndrome, later developed septic shock and died in September 2016 (179) . The causative pathogen, carbapenem-resistant K. pneumoniae, was resistant to all 26 antibiotics approved for her treatment in the United States. Antibiotic resistance is expanding and spreading worldwide at a far higher rate than that of the discovery of and eventual approval of new antimicrobials for clinical use. Ineffective and limited choices for empirical treatment would increase the rate of morbidity and mortality in patients, because simple bacterial infections are allowed more time to establish secondary invasion, which could be highly lethal. AMP-based antibiotics represent the most promising candidates to be developed as new-generation antimicrobial agents. The continuous discovery of natural AMPs from various sources will further expand the AMP database currently known to humans. These natural AMPs are valuable leads in the design of AMP variants with improved therapeutic profiles as the new-generation antibiotics.
